Venture sentiment turns sour
Venionaire’s EVSI report says investor sentiment toward startups has cooled sharply in Q1 2026, with capital still available but at higher standards and with less patience. The shift means founders and boards are treating compensation and equity design more strategically as capital efficiency becomes central to survival. (venionaire.com)
The strange part of venture capital in early 2026 is that the money did not disappear. Venionaire says European startup investment in the first quarter rose to about $21.3 billion, but that cash was spread across fewer companies and investors got much colder about the average founder. (venionaire.com) Venionaire’s European Venture Sentiment Index landed at 4.4 in the first quarter of 2026, below the 5.6 projection, down 22.7% from the fourth quarter of 2025, and down 26.1% from a year earlier. The firm says that gap shows investors entered 2026 more cautious than they expected even a few months earlier. (venionaire.com) Berthold Baurek-Karlic, the chief executive of Venionaire Capital, summed it up bluntly: more capital is chasing fewer startups. That is why a founder can open the news, see giant funding rounds, and still get told no by 20 firms in a row. (venionaire.com) That split is not just a Europe story. Crunchbase says global startup funding hit about $297 billion in the first quarter of 2026, but the quarter was dominated by a small number of giant artificial intelligence deals rather than a broad reopening for ordinary software, health, or consumer startups. (news.crunchbase.com) PitchBook describes the same market as “the magnificent few,” with capital concentration reaching historic extremes and fund managers still dealing with weak distributions back to their own investors. When venture firms are waiting longer to get cash back from exits, they usually become pickier about every new check they write. (pitchbook.com) That change shows up inside startups long before it shows up in a press release. If investors expect slower growth and faster proof, boards stop treating hiring plans, salary bands, and stock option grants like generous recruiting tools and start treating them like runway math. (venionaire.com) A stock option is the promise that an employee can buy shares later at a preset price. In a softer market, that promise gets redesigned more carefully, because a grant that looked motivating at a 2024 valuation can feel useless if the next round comes in flat or lower. (venionaire.com) Rock Health, looking at health technology funding in the same quarter, said the market is becoming more bifurcated and that capital continues to concentrate. That is another way of saying investors still fund companies, but they increasingly fund the ones that already look like winners. (rockhealth.com) For founders, the old pitch of “we will grow first and figure out efficiency later” is getting harder to sell in April 2026 than it was in 2021 or even 2024. Investors now want evidence on burn, payback, hiring discipline, and how long the company can survive if the next round takes 12 months longer than planned. (venionaire.com)
